Literature DB >> 10942409

Hydroxyurea-induced marked oscillations of platelet counts in patients with polycythemia vera.

A Tefferi1, M A Elliott, P C Kao, S Yoon, I El-Hemaidi, T C Pearson.   

Abstract

Two prospectively studied patients with polycythemia vera (PV) whose platelet counts showed marked periodic fluctuation during treatment with hydroxyurea (HU) are reported. Cycle lengths in both were approximately 28 to 30 days. In one patient, the cyclic process was no longer evident when treatment with HU was withheld, and it reappeared on treatment rechallenge. Circulating thrombopoietin (TPO) levels fluctuated out of phase with the platelet count despite markedly reduced TPO-receptor (c-Mpl) expression in bone marrow megakaryocytes. These observations suggest that the cyclic phenomenon may be related to both a transient state of HU-induced depletion of megakaryocytes and a concentration-dependent mitigation by TPO of the HU effect on megakaryocytes and their precursors. It is conceivable that the affected patients harbor a megakaryocyte progenitor pool whose apoptotic activity is differently modulated by either HU or high concentrations of TPO. (Blood. 2000;96:1582-1584)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942409

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Hydroxyurea induced oscillations in twelve patients with polycythemia vera.

Authors:  Jan Tauscher; Fabian Siegel; Petro E Petrides
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

2.  Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide.

Authors:  John H Baird; Caterina P Minniti; Jung-Min Lee; Xin Tian; Colin Wu; Mary Jackson; Shoaib Alam; James G Taylor; Gregory J Kato
Journal:  Br J Haematol       Date:  2014-11-06       Impact factor: 6.998

3.  Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.

Authors:  Alberto Tosetto; Bianca Rocca; Giovanna Petrucci; Silvia Betti; Denise Soldati; Elena Rossi; Andrea Timillero; Viviana Cavalca; Benedetta Porro; Alessandra Iurlo; Daniele Cattaneo; Cristina Bucelli; Alfredo Dragani; Mauro Di Ianni; Paola Ranalli; Francesca Palandri; Nicola Vianelli; Eloise Beggiato; Giuseppe Lanzarone; Marco Ruggeri; Giuseppe Carli; Elena Maria Elli; Stefania Priolo; Maria Luigia Randi; Irene Bertozzi; Giuseppe Gaetano Loscocco; Alessandra Ricco; Giorgina Specchia; Alessandro Maria Vannucchi; Francesco Rodeghiero; Valerio De Stefano; Carlo Patrono
Journal:  Clin Pharmacol Ther       Date:  2021-11-20       Impact factor: 6.903

4.  Thrombosis in Myeloproliferative Neoplasms: A Single Center Experience of Using Whole Blood Platelet Aggregation Studies for Risk Assessment and Thromboprophylaxis.

Authors:  Arumugam Manoharan; Rosalie Gemmell; Lauren Cavanaugh; Noor Shadood
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.